Enantioselective Aminomethylation of 1-(Benzyloxy)propan-2-one with 4-Methyl-2-[(prop-2-en-1-yl)oxy]aniline

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Enantioselective catalytic ternary aminomethylation of 1-(benzyloxy)propan-2-one with 4-methyl-2-[(prop-2-en-1-yl)oxy]aniline in the presence of a chiral catalyst pseudoephedrine in an aqueous medium leads to anti/syn products – optically pure aminoketoseters of the aromatic series with high yields. The structure of the obtained compounds was confirmed by 1H, 13C NMR spectroscopy and mass spectrometry data. Diasteromeric purity (de) was determined using chiral HPLC. This reaction can also be used to form a C-C bond. The ratio of diasteroeisomers was determined depending on the temperature and the solvent used.

Sobre autores

G. Talybov

Azerbaijan Technical University

Email: gtalibov61@gmail.com
ORCID ID: 0000-0001-6251-2974
Baku, Azerbaijan

Bibliografia

  1. Kobayashi S., Ishitani H. Chem. Rev. 1999, 99, 1069.
  2. Diego J.R., Miguel Y. Angew. Chem., Int. Ed. 2005, 44, 1602.
  3. Armstrong R.W., Combs A.P. Acc. Chem. Res. 1996, 29, 123.
  4. Lee A.C.-H., Poulsen A., Goh K.Ch., Madan B., Hart S., Tan E., Wang H., Nagaraj H., Chen D., Lee Ch.P., Sun E.T., Jayaraman R., Khalid Pasha M., Ethirajulu K., Wood J.M., and Dymock B.W. J. Med. Chem. 2012, 55, 2623–2640. doi: 10.1021/jm201454n
  5. Kalir A., Teomy Sh., Amir A., Fuchs P., Lee S.A., Holszynska E.H., Rocki W., Domino E.F. J. Med. Chem. 1984, 27, 1267–1271. doi: 10.1021/jm003760006
  6. Джафаров И.А., Мамедбейли Э.Г., Джафарова Н.А., Талыбов Г.М. ЖОрД 2019, 55, 538–546. doi: 10.1134/S1070428019040055
  7. Маркова И.В., Михайлов И.Б., Неженцев М.В. Фармаколозия. С.-Петербург: Фолиант, 2001.
  8. Lindström U.M. Chem. Rev. 2002, 102, 2751–2772. doi: 10.1021/cr010122p

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Russian Academy of Sciences, 2025